Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes - Cybin...

Javier Gasse
Wed, May 24
Canadian clinical-stage psychedelics company Cybin Inc. (NYSE: CYBN) announced that the first group of participants have been dosed with its proprietary deuterated DMT molecule, CYB004, in an ongoing
Discover